Condition
Cancer|Neoplasms|Tumors
Estimated Enrollment: 0
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: IRB00047570|WCI1895-10
Study First Received: December 20, 2011
Last Updated: November 19, 2013
Estimated Primary Completion Date: October 2013
Primary Outcome Measures:
Assessment of dose-limiting toxicity|Progression-free survival
Sponsors and Collaborators:
Emory University|OSI Pharmaceuticals
Website Link: https://ClinicalTrials.gov/show/NCT01567384
